Clinical Trial Results:
A Double-Blind, Randomized, Placebo-controlled Study of Two Different Schedules of Palifermin (Pre- and Post Chemotherapy and Pre-Chemotherapy only) for Reduction in Severity of Oral Mucositis in Subjects with Multiple Myeloma (MM) Receiving High Dose Melphalan followed by Autologous Peripheral Blood Stem Cell Transplantation (PBSCT)
Summary
|
|
EudraCT number |
2006-003709-15 |
Trial protocol |
GB HU CZ IE AT BE FI SE DE DK IT NL |
Global completion date |
22 Nov 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
10 Jun 2016
|
First version publication date |
10 Jun 2016
|
Other versions |
|
Summary report(s) |
2005219 Summary Table 14.2.1.1.1 Table 14.2.1.1.3 Table 13.2.1.1.4 Table 14.2.1.2.1 Table 14.2.1.3.6 Table 14.2.1.6.1 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.